Literature DB >> 21577614

4-Amino-3-[(4-methoxy-phen-yl)amino-meth-yl]-1H-1,2,4-triazole-5(4H)-thione.

Hoong-Kun Fun, Chin Sing Yeap, Shridhar Malladi, Mahesh Padaki, Arun M Isloor.   

Abstract

The mol-ecule of the title compound, C(10)H(13)N(5)OS, is approximately planar, the dihedral angle between the triazole and benzene rings being 4.53 (10)°. The amino group adopts a pyramidal configuration. In the crystal structure, mol-ecules are linked into two-dimensional networks parallel to (001) by inter-molecular N-H⋯S and N-H⋯N hydrogen bonds. In addition, an S⋯S short contact of 3.3435 (7) Å is observed.

Entities:  

Year:  2009        PMID: 21577614      PMCID: PMC2969966          DOI: 10.1107/S1600536809032607

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the pharmacological applications of 1,2,4-triazole derivatives, see: Amir et al. (2008 ▶); Isloor et al. (2009 ▶); Krzysztof et al. (2008 ▶); Kuş et al. (2008 ▶); Padmavathi et al. (2008 ▶). For the preparation, see: Holla & Udupa (1992 ▶). For related structures, see: Fun et al. (2009a ▶,b ▶). For the stability of the temperature controller used for data collection, see: Cosier & Glazer (1986 ▶).

Experimental

Crystal data

C10H13N5OS M = 251.31 Monoclinic, a = 11.5142 (2) Å b = 5.8804 (1) Å c = 16.6891 (3) Å β = 95.292 (1)° V = 1125.17 (3) Å3 Z = 4 Mo Kα radiation μ = 0.28 mm−1 T = 100 K 0.33 × 0.18 × 0.02 mm

Data collection

Bruker SMART APEXII CCD area-detector diffractometer Absorption correction: multi-scan (; Bruker, 2005 ▶) T min = 0.913, T max = 0.994 5827 measured reflections 2365 independent reflections 2126 reflections with I > 2σ(I) R int = 0.024

Refinement

R[F 2 > 2σ(F 2)] = 0.031 wR(F 2) = 0.068 S = 1.04 2365 reflections 171 parameters 1 restraint H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.33 e Å−3 Δρmin = −0.26 e Å−3 Absolute structure: Flack (1983 ▶), 588 Friedel pairs Flack parameter: 0.03 (7) Data collection: APEX2 (Bruker, 2005 ▶); cell refinement: SAINT (Bruker, 2005 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 ▶). Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536809032607/ci2889sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536809032607/ci2889Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C10H13N5OSF(000) = 528
Mr = 251.31Dx = 1.484 Mg m3
Monoclinic, C2Mo Kα radiation, λ = 0.71073 Å
Hall symbol: C 2yCell parameters from 2961 reflections
a = 11.5142 (2) Åθ = 3.6–32.2°
b = 5.8804 (1) ŵ = 0.28 mm1
c = 16.6891 (3) ÅT = 100 K
β = 95.292 (1)°Plate, colourless
V = 1125.17 (3) Å30.33 × 0.18 × 0.02 mm
Z = 4
Bruker SMART APEXII CCD area-detector diffractometer2365 independent reflections
Radiation source: fine-focus sealed tube2126 reflections with I > 2σ(I)
graphiteRint = 0.024
φ and ω scansθmax = 30.0°, θmin = 3.6°
Absorption correction: multi-scan (SADABS; Bruker, 2005)h = −15→16
Tmin = 0.913, Tmax = 0.994k = −8→5
5827 measured reflectionsl = −23→23
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.031H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.068w = 1/[σ2(Fo2) + (0.0277P)2 + 0.6764P] where P = (Fo2 + 2Fc2)/3
S = 1.04(Δ/σ)max = 0.001
2365 reflectionsΔρmax = 0.33 e Å3
171 parametersΔρmin = −0.25 e Å3
1 restraintAbsolute structure: Flack (1983), 588 Friedel pairs
Primary atom site location: structure-invariant direct methodsFlack parameter: 0.03 (7)
Experimental. The crystal was placed in the cold stream of an Oxford Cyrosystems Cobra open-flow nitrogen cryostat (Cosier & Glazer, 1986) operating at 100.0 (1) K.
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
S10.37035 (4)0.34412 (9)0.03759 (3)0.01571 (11)
O1−0.26796 (11)1.2919 (3)0.42305 (8)0.0248 (4)
N10.07536 (13)0.3929 (3)0.13658 (9)0.0171 (4)
N20.15394 (14)0.2872 (3)0.09067 (10)0.0164 (4)
N30.23563 (13)0.5947 (3)0.13167 (9)0.0136 (3)
N4−0.02128 (14)0.6826 (3)0.24608 (10)0.0167 (4)
N50.30984 (14)0.7845 (3)0.14247 (10)0.0171 (4)
C10.25184 (15)0.4074 (3)0.08580 (11)0.0144 (4)
C20.12844 (15)0.5803 (4)0.16083 (11)0.0138 (4)
C30.08129 (16)0.7617 (4)0.21027 (12)0.0158 (4)
H3A0.14040.80720.25240.019*
H3B0.06130.89330.17680.019*
C4−0.08548 (14)0.8413 (4)0.28707 (10)0.0146 (3)
C5−0.04122 (16)1.0556 (4)0.31036 (12)0.0174 (4)
H5A0.03071.10190.29500.021*
C6−0.10392 (16)1.1985 (4)0.35610 (12)0.0187 (4)
H6A−0.07321.33980.37150.022*
C7−0.21184 (16)1.1350 (4)0.37941 (11)0.0168 (4)
C8−0.25711 (16)0.9225 (4)0.35578 (11)0.0174 (4)
H8A−0.32950.87760.37080.021*
C9−0.19487 (15)0.7792 (4)0.31039 (11)0.0163 (4)
H9A−0.22610.63840.29490.020*
C10−0.37125 (17)1.2205 (4)0.45705 (12)0.0219 (5)
H10A−0.39821.34060.48960.033*
H10B−0.35451.08810.48970.033*
H10C−0.43051.18480.41470.033*
H1N20.1335 (18)0.175 (4)0.0617 (13)0.016 (6)*
H1N4−0.063 (2)0.601 (5)0.2156 (15)0.032 (7)*
H1N50.381 (2)0.728 (5)0.1550 (16)0.047 (8)*
H2N50.3141 (19)0.845 (6)0.0921 (15)0.042 (7)*
U11U22U33U12U13U23
S10.01344 (18)0.0157 (2)0.0184 (2)0.0019 (2)0.00344 (15)−0.0002 (2)
O10.0220 (7)0.0201 (9)0.0342 (8)−0.0015 (6)0.0123 (6)−0.0096 (7)
N10.0157 (7)0.0161 (10)0.0201 (8)−0.0007 (7)0.0052 (6)0.0000 (7)
N20.0186 (7)0.0117 (9)0.0197 (8)−0.0021 (6)0.0050 (6)−0.0030 (7)
N30.0126 (7)0.0149 (9)0.0135 (7)−0.0008 (6)0.0015 (6)−0.0003 (7)
N40.0150 (8)0.0149 (9)0.0208 (9)−0.0039 (7)0.0051 (7)−0.0033 (7)
N50.0142 (7)0.0148 (9)0.0220 (9)−0.0050 (6)0.0006 (6)−0.0019 (7)
C10.0143 (8)0.0155 (10)0.0135 (8)0.0025 (7)0.0011 (7)0.0001 (7)
C20.0132 (8)0.0156 (10)0.0126 (9)0.0022 (7)0.0015 (7)0.0029 (8)
C30.0151 (8)0.0140 (10)0.0183 (9)−0.0012 (7)0.0020 (7)0.0006 (8)
C40.0153 (7)0.0154 (9)0.0132 (7)0.0032 (9)0.0012 (6)0.0006 (10)
C50.0139 (9)0.0176 (11)0.0211 (10)−0.0015 (8)0.0043 (7)0.0005 (8)
C60.0188 (9)0.0146 (10)0.0228 (10)−0.0027 (8)0.0020 (8)−0.0037 (8)
C70.0174 (9)0.0165 (10)0.0167 (9)0.0015 (8)0.0030 (7)−0.0005 (8)
C80.0157 (9)0.0184 (10)0.0187 (9)−0.0014 (8)0.0044 (7)0.0013 (8)
C90.0163 (8)0.0121 (10)0.0203 (9)−0.0024 (7)0.0002 (7)−0.0006 (8)
C100.0177 (9)0.0258 (13)0.0228 (10)0.0016 (9)0.0057 (8)−0.0032 (9)
S1—C11.6883 (18)C3—H3A0.97
O1—C71.373 (2)C3—H3B0.97
O1—C101.427 (2)C4—C51.401 (3)
N1—C21.306 (3)C4—C91.401 (2)
N1—N21.386 (2)C5—C61.383 (3)
N2—C11.339 (2)C5—H5A0.93
N2—H1N20.84 (2)C6—C71.387 (3)
N3—C11.364 (3)C6—H6A0.93
N3—C21.370 (2)C7—C81.397 (3)
N3—N51.407 (2)C8—C91.377 (3)
N4—C41.407 (3)C8—H8A0.93
N4—C31.448 (2)C9—H9A0.93
N4—H1N40.82 (3)C10—H10A0.96
N5—H1N50.89 (3)C10—H10B0.96
N5—H2N50.92 (3)C10—H10C0.96
C2—C31.482 (3)
C7—O1—C10117.60 (17)H3A—C3—H3B108.1
C2—N1—N2103.83 (15)C5—C4—C9118.09 (18)
C1—N2—N1113.14 (16)C5—C4—N4122.53 (16)
C1—N2—H1N2125.0 (14)C9—C4—N4119.3 (2)
N1—N2—H1N2120.6 (14)C6—C5—C4120.33 (17)
C1—N3—C2108.88 (16)C6—C5—H5A119.8
C1—N3—N5126.84 (15)C4—C5—H5A119.8
C2—N3—N5124.04 (17)C5—C6—C7121.20 (19)
C4—N4—C3118.22 (18)C5—C6—H6A119.4
C4—N4—H1N4112.7 (18)C7—C6—H6A119.4
C3—N4—H1N4112.5 (17)O1—C7—C6116.46 (18)
N3—N5—H1N5105.8 (19)O1—C7—C8124.69 (17)
N3—N5—H2N5105.9 (18)C6—C7—C8118.83 (18)
H1N5—N5—H2N5103 (2)C9—C8—C7120.19 (17)
N2—C1—N3103.45 (15)C9—C8—H8A119.9
N2—C1—S1129.38 (15)C7—C8—H8A119.9
N3—C1—S1127.15 (15)C8—C9—C4121.4 (2)
N1—C2—N3110.68 (18)C8—C9—H9A119.3
N1—C2—C3126.50 (17)C4—C9—H9A119.3
N3—C2—C3122.78 (18)O1—C10—H10A109.5
N4—C3—C2110.69 (17)O1—C10—H10B109.5
N4—C3—H3A109.5H10A—C10—H10B109.5
C2—C3—H3A109.5O1—C10—H10C109.5
N4—C3—H3B109.5H10A—C10—H10C109.5
C2—C3—H3B109.5H10B—C10—H10C109.5
C2—N1—N2—C1−0.9 (2)N3—C2—C3—N4−168.35 (17)
N1—N2—C1—N31.1 (2)C3—N4—C4—C5−14.9 (3)
N1—N2—C1—S1179.40 (14)C3—N4—C4—C9169.36 (17)
C2—N3—C1—N2−0.9 (2)C9—C4—C5—C61.0 (3)
N5—N3—C1—N2−175.43 (17)N4—C4—C5—C6−174.84 (19)
C2—N3—C1—S1−179.25 (15)C4—C5—C6—C7−0.5 (3)
N5—N3—C1—S16.3 (3)C10—O1—C7—C6−171.73 (18)
N2—N1—C2—N30.2 (2)C10—O1—C7—C810.0 (3)
N2—N1—C2—C3177.94 (18)C5—C6—C7—O1−178.46 (18)
C1—N3—C2—N10.4 (2)C5—C6—C7—C8−0.1 (3)
N5—N3—C2—N1175.13 (17)O1—C7—C8—C9178.47 (18)
C1—N3—C2—C3−177.35 (17)C6—C7—C8—C90.2 (3)
N5—N3—C2—C3−2.7 (3)C7—C8—C9—C40.2 (3)
C4—N4—C3—C2−172.48 (15)C5—C4—C9—C8−0.8 (3)
N1—C2—C3—N414.2 (3)N4—C4—C9—C8175.13 (18)
D—H···AD—HH···AD···AD—H···A
N2—H1N2···S1i0.84 (2)2.55 (2)3.3672 (18)164 (2)
N4—H1N4···N5ii0.82 (3)2.60 (3)3.410 (2)169 (3)
N5—H1N5···N1iii0.89 (2)2.48 (2)3.133 (2)130 (2)
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N2—H1N2⋯S1i0.84 (2)2.55 (2)3.3672 (18)164 (2)
N4—H1N4⋯N5ii0.82 (3)2.60 (3)3.410 (2)169 (3)
N5—H1N5⋯N1iii0.89 (2)2.48 (2)3.133 (2)130 (2)

Symmetry codes: (i) ; (ii) ; (iii) .

  10 in total

1.  Synthesis, spectral studies and biological activities of some N-bridged heterocycles derived from 3-arylaminomethyl-4-amino-5-mercapto-1,2,4-triazoles.

Authors:  B S Holla; K V Udupa
Journal:  Farmaco       Date:  1992-03

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Regioselective reaction: synthesis, characterization and pharmacological studies of some new Mannich bases derived from 1,2,4-triazoles.

Authors:  Arun M Isloor; Balakrishna Kalluraya; Prashanth Shetty
Journal:  Eur J Med Chem       Date:  2009-05-05       Impact factor: 6.514

4.  4-Amino-3-(o-tolyl-oxymeth-yl)-1H-1,2,4-triazole-5(4H)-thione.

Authors:  Hoong-Kun Fun; Wei-Ching Liew; A M Vijesh; Mahesh Padaki; Arun M Isloor
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-07-18

5.  4-Amino-3-(p-tolyl-oxymeth-yl)-1H-1,2,4-triazole-5(4H)-thione.

Authors:  Hoong-Kun Fun; Jia Hao Goh; A M Vijesh; Mahesh Padaki; Arun M Isloor
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-07-18

6.  Condensed bridgehead nitrogen heterocyclic system: synthesis and pharmacological activities of 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives of ibuprofen and biphenyl-4-yloxy acetic acid.

Authors:  Mohd Amir; Harish Kumar; S A Javed
Journal:  Eur J Med Chem       Date:  2007-10-06       Impact factor: 6.514

7.  Synthesis and antioxidant properties of novel N-methyl-1,3,4-thiadiazol-2-amine and 4-methyl-2H-1,2,4-triazole-3(4H)-thione derivatives of benzimidazole class.

Authors:  Canan Kuş; Gülgün Ayhan-Kilcigil; Süheyla Ozbey; F Betül Kaynak; Melek Kaya; Tülay Coban; Benay Can-Eke
Journal:  Bioorg Med Chem       Date:  2008-02-29       Impact factor: 3.641

8.  Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.

Authors:  Krzysztof Sztanke; Tomasz Tuzimski; Jolanta Rzymowska; Kazimierz Pasternak; Martyna Kandefer-Szerszeń
Journal:  Eur J Med Chem       Date:  2007-04-14       Impact factor: 6.514

9.  Synthesis and antimicrobial activity of novel sulfone-linked bis heterocycles.

Authors:  V Padmavathi; P Thriveni; G Sudhakar Reddy; D Deepti
Journal:  Eur J Med Chem       Date:  2007-07-06       Impact factor: 6.514

10.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  10 in total
  1 in total

1.  N-[(4-Amino-5-sulfanyl-idene-4,5-dihydro-1H-1,2,4-triazol-3-yl)meth-yl]-4-methyl-benzamide.

Authors:  Hoong-Kun Fun; Chin Sing Yeap; Yatin Mange; Arun M Isloor; Chitrakar Hegde
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-09-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.